ORAGENICS INC Business Finance Contracts & Agreements
103 Contracts & Agreements
- Assignment Agreements (2 contracts)
- Credit Agreements (3)
- Exchange Agreements (1)
- Guaranty Agreements (1)
- Joinder Agreements (1)
- Loan Agreements (4)
- Note Agreements (23)
- Purchase Agreements (11)
- Registration Rights Agreements (3)
- Security Agreements (2)
- Stock Agreements (23)
- Underwriting Agreements (7)
- Warrant Agreements (22)
- Form of Securities Purchase Agreement (Filed With SEC on September 5, 2024)
- Warrant Agency Agreement (Filed With SEC on September 5, 2024)
- Form of Placement Agent Warrant (Filed With SEC on September 5, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on September 5, 2024)
- Form of Placement Agent Warrant (Filed With SEC on June 26, 2024)
- Underwriting Agreement dated February 27, 2024 between Oragenics, Inc. and ThinkEquity LLC (Filed With SEC on March 1, 2024)
- Asset Purchase Agreement (Filed With SEC on October 5, 2023)
- Form of Restricted Stock Award Agreement (Filed With SEC on August 10, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on August 7, 2023)
- Specimen Stock Certificate (Filed With SEC on January 23, 2023)
- Form Stock Option Award Agreement (Consultants) (Filed With SEC on February 28, 2022)
- Form Stock Option Award Agreement (Employees) (Filed With SEC on February 28, 2022)
- Form Stock Option Award Agreement (Directors) (Filed With SEC on February 28, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on December 28, 2020)
- Underwriting Agreement dated November 19, 2020 (Filed With SEC on November 24, 2020)
- Stock Purchase Agreement, dated May 1, 2020 (Filed With SEC on May 4, 2020)
- Warrant, dated May 1, 2020 (Filed With SEC on May 4, 2020)
- Form of Notice of Grant of Stock Options and Stock Option Award Agreement (Directors) (Filed With SEC on March 4, 2020)
- Notice of Assignment of Lantibiotic ECC and Lantibiotic SIA by and between Oragenics, Inc. and Intrexon Corporation (n/k/a Precigen Inc.) to ILH Holdings Inc. effective January 1,... (Filed With SEC on March 4, 2020)
- Specimen Stock Certificate (Filed With SEC on March 29, 2019)
- Form of Series 2 Warrant (Filed With SEC on March 25, 2019)
- Form of Series 1 Warrant (Filed With SEC on March 25, 2019)
- Underwriting Agreement dated March 21, 2019 (Filed With SEC on March 25, 2019)
- Warrant Agency Agreement (Filed With SEC on July 17, 2018)
- Form of Warrant (Filed With SEC on July 17, 2018)
- Underwriting Agreement dated as of July 13, 2017 by and between Oragenics, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on July 17, 2018)
- Form of Warrant to purchase shares of Common Stock (Filed With SEC on July 11, 2018)
- Form of Warrant to purchase shares of Common Stock (Filed With SEC on July 9, 2018)
- Form of Certificate of Designation of Series D Preferred Stock (Filed With SEC on July 9, 2018)
- Form of Underwriting Agreement (Filed With SEC on July 9, 2018)
- Form of Securities Purchase Agreement, dated as of April 6, 2018, by and among Oragenics, Inc. and the Investors (Filed With SEC on April 10, 2018)
- Form of Investor Warrant (Filed With SEC on April 10, 2018)
- Joinder to Assignment of Oral Mucositis SIA by and between Oragenics, Inc. and Intrexon Corporation between Oragenics, Inc. and Intrexon Corporation, effective January 1, 2018 (Filed With SEC on February 16, 2018)
- Notice of Assignment to Oral Mucositis SIA by and between Oragenics, Inc. and Intrexon Corporation between Oragenics, Inc. and Intrexon Corporation, effective January 1, 2018 (Filed With SEC on February 16, 2018)
- Second Amendment to Stock Issuance Agreement between Oragenics, Inc. and Intrexon Corporation dated November 8, 2017 (Filed With SEC on November 9, 2017)
- Amendment to Stock Issuance Agreement between Oragenics, Inc. and Intrexon Corporation dated November 8, 2017 (Filed With SEC on November 9, 2017)
- Registration Rights Agreement dated November 8, 2017 (Filed With SEC on November 9, 2017)
- Securities Purchase Agreement dated November 8, 2017 (Filed With SEC on November 9, 2017)
- Form of Common Stock Purchase Warrant (Filed With SEC on November 9, 2017)
- AGREEMENT TO AMEND COMMON STOCK WARRANTS (Filed With SEC on August 1, 2017)
